Patents by Inventor Lee Adrian Davies

Lee Adrian Davies has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10704061
    Abstract: This invention relates to lentiviral gene transfer vectors pseudotyped with hemagglutinin-neuraminidase (HN) and fusion (F) proteins from a respiratory paramyxovirus, comprising a promoter and a transgene; and methods of making the same. The present invention also relates to the use of said vectors in gene therapy, particularly for the treatment of respiratory tract diseases such as Cystic Fibrosis (CF).
    Type: Grant
    Filed: April 23, 2015
    Date of Patent: July 7, 2020
    Assignees: IP2IPO INNOVATIONS LIMITED, ID PHARMA CO., LTD.
    Inventors: Eric Walter Frederick Wolfgang Alton, Uta Griesenbach, Kamila Malgorzata Pytel, Michael Christian Paul-Smith, Ian Andrew Pringle, Stephen Charles Hyde, Deborah Rebecca Gill, Lee Adrian Davies, Alan Christopher Boyd, Gerard McLachlan, Makoto Inoue
  • Publication number: 20170096684
    Abstract: This invention relates to lentiviral gene transfer vectors pseudotyped with hemagglutinin-neuraminidase (HN) and fusion (F) proteins from a respiratory paramyxovirus, comprising a promoter and a transgene; and methods of making the same. The present invention also relates to the use of said vectors in gene therapy, particularly for the treatment of respiratory tract diseases such as Cystic Fibrosis (CF).
    Type: Application
    Filed: April 23, 2015
    Publication date: April 6, 2017
    Inventors: Eric Walter Frederick Wolfgang Alton, Uta Griesenbach, Kamila Malgorzata Pytel, Michael Christian Paul-Smith, Ian Andrew Pringle, Stephen Charles Hyde, Deborah Rebecca Gill, Lee Adrian Davies, Alan Christopher Boyd, Gerard McLachlan, Makoto Inoue
  • Patent number: 7883032
    Abstract: Methods are described of delivering biological material, which methods include the steps of providing a liquid formulation containing the biological material, supplying the liquid formulation to an outlet and subjecting liquid issuing from the outlet to an electrical field thereby causing electrohydrodynamic processing of the liquid without denaturing the biological material. In one example, the liquid formulation is provided by removing salts from a formulation containing biological material that does not denature in alcohol and then adding an alcohol to the formulation before supplying the liquid formulation to the outlet. An acid may be added to the liquid formulation before supplying the liquid formulation to the outlet.
    Type: Grant
    Filed: April 3, 2001
    Date of Patent: February 8, 2011
    Assignee: Battelle Memorial Institute
    Inventors: Lee Adrian Davies, David Neville Davies, Margaret Sin Ka Wan, Ronald Alan Coffee
  • Publication number: 20030173219
    Abstract: Methods are described of delivering biological material, which methods include the steps of providing a liquid formulation containing the biological material, supplying the liquid formulation to an outlet and subjecting liquid issuing from the outlet to an electrical field thereby causing electrohydrodynamic processing of the liquid without denaturing the biological material. In one example, the liquid formulation is provided by removing salts from a formulation containing biological material that does not denature in alcohol and then adding an alcohol to the formulation before supplying the liquid formulation to the outlet. An acid may be added to the liquid formulation before supplying the liquid formulation to the outlet.
    Type: Application
    Filed: May 16, 2003
    Publication date: September 18, 2003
    Inventors: Lee Adrian Davies, David Neville Davies, Margaret Sin Ka Wan, Ronald Alan Coffee